A $4.75m grant will support the development of EIS-12656, which is being studied alone and in combination with PARP ...

Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...

GSK has reported that the double-blind, randomised Phase III FIRST-ENGOT-OV44 trial of Zejula (niraparib) and Jemperli ...

The best candle brands are based on our team's collective love for good candles and our own experiences. We look for sustainable practices and high quality materials, good throw (how well a scent ...

"The OlympiA trial examines adding one year of the oral PARP inhibitor olaparib after completion of standard treatment for higher risk breast cancer in individuals with pathogenic germline BRCA ...

Bids do not include VAT, buyer’s premium or delivery. By confirming your bid, you agree that you have read and accepted bidspotter.co.uk and the auctioneer's terms and conditions. Confirming your bid ...

Merck hasn’t had much luck pairing cancer superstar Keytruda with PARP inhibitor Lynparza. But after flunking three clinical trials with the combination, the company has emerged with a tepid win ...

The WNBA's success in 2024 has now been quantified and compared to other brands — and the results are staggering. Aug 30, 2024; Chicago, Illinois, USA; Indiana Fever guard Caitlin Clark (22 ...

After the NHL Board of Governors meeting Monday, top officials from the Utah Hockey Club and the NHL chatted about the development of the team’s permanent brand identity. Utah owner Ryan Smith ...